SCHEMBL11903401

SCHEMBL11903401

Cc1cn[nH]c1-c1sc(N2CCOCC2)cc1-c1ccc(Cl)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 1/20 0.44
MTOR P42345 1/20 0.44
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
AR P10275 1/20 0.43
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42
CRHR1 P34998 1/20 0.40
ALPL P05186 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
PRKDC P78527 2/20 0.37
DPP4 P27487 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TP53 P04637 1/20 0.37
HPGD P15428 1/20 0.37
CNR2 P34972 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
ATR Q13535 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6726849 0.78 PIK3CA (0.51) PIK3CAMTORRAB9ANPC1AR
SCHEMBL6752237 0.78 PIK3CA (0.70) PIK3CAMTORRAB9ANPC1AR
SCHEMBL11902424 0.78 CRHR1 (0.46) PIK3CAMTORRAB9ANPC1AR
SCHEMBL11902997 0.75 RAB9A (0.44) PIK3CAMTORRAB9ANPC1AR
SCHEMBL11903039 0.73 RAB9A (0.42) PIK3CAMTORRAB9ANPC1AR
SCHEMBL11917978 0.71 PIK3CA (0.60) PIK3CAMTORHSP90AA1HSP90AB1
SCHEMBL11903299 0.66 ESR1 (0.38) PIK3CAMTORRAB9ANPC1AR
SCHEMBL11997568 0.65 PRKDC (0.40) PIK3CAMTORHSP90AA1HSP90AB1MEN1
SCHEMBL11902645 0.65 PRKDC (0.40) PIK3CAMTORRAB9ANPC1PRKDC
SCHEMBL11903062 0.65 PRKDC (0.40) PIK3CAMTORRAB9ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8440664-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-05-14 US disclosed
US-20120202812-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202812-A1 HETEROARYLS AND USES THEREOF PIK3R3, AKT1S1, PIK3R1 PIK3CA 11/4885MTOR 148/4885RAB9A 2320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.